Skip to content
Home/Companies/Healthcare/Shenzhen Salubris Pharmaceutical Co., Ltd

Shenzhen Salubris Pharmaceutical Co., Ltd

Healthcare·China·Exited
Entry
–
Hold
–
Exit
–

Who owns Shenzhen Salubris Pharmaceutical Co., Ltd?

Shenzhen Salubris Pharmaceutical Co., Ltd was owned by The Carlyle Group through Carlyle Sub-Saharan Africa Fund (2018 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Sub-Saharan Africa Fund · 2018 · Buyout

Key facts

HQChina
SectorHealthcare
Exit Type
–
Buyer
–
MOIC
–
Exit Year
–

More from Carlyle Sub-Saharan Africa Fund

Other portfolio companies in the same fund.

A Twosome Place
Active
ConsumerUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
HealthcareUS
Accolade Wines
Active
ConsumerAustralia
Amecor
Exited 2024
TMTUS
to
Amrod
Amrod
Exited 2023
ConsumerUS
to
CMC Networks
CMC Networks
Active
TMTSouth Africa

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Adagene
Active
General AtlanticChina
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Shenzhen Salubris Pharmaceutical Co., Ltd

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Shenzhen Salubris Pharmaceutical Co., Ltd.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue